Stay updated on FG-3019 in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the FG-3019 in Diabetic Kidney Disease Clinical Trial page
- Check4 days agoChange DetectedRelevant study descriptors and history entries have been removed from the record, including the investigational drug pamrevlumab (FG-3019) and several disease/condition terms related to diabetes and kidney disease, along with administrative dates. This alters how the study is categorized and surfaced in the registry, affecting searchability and interpretation by users.SummaryDifference17%

- Check11 days agoChange DetectedThe page revision has been updated from v3.6.6 to v3.7.0, indicating a new version of the study page was published.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.6 has been added on the page, signaling a software version update for the study page. This update does not modify trial details, eligibility criteria, or locations.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, representing a minor software version update. This change signals an updated build of the page but does not modify the study information presented.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision metadata updated from v3.6.3 to v3.6.4 on the page.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.1, indicating a minor platform update rather than a change to study details or results.SummaryDifference0.0%

Stay in the know with updates to FG-3019 in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.